Know Cancer

or
forgot password

A Prospective Randomized Controlled Trial Comparing Isolated Roux-en-Y Reconstruction With Billroth-II-type Reconstruction After Pancreaticoduodenectomy


N/A
20 Years
N/A
Open (Enrolling)
Both
Pancreatic Neoplasms, Bile Duct Neoplasms, Ampullary Neoplasms, Duodenal Neoplasms, Pancreatitis

Thank you

Trial Information

A Prospective Randomized Controlled Trial Comparing Isolated Roux-en-Y Reconstruction With Billroth-II-type Reconstruction After Pancreaticoduodenectomy


The purpose of this study is to clarify whether isolated Roux-en-Y reconstruction declines
the incidence of postoperative complications after pancreaticoduodenectomy compared with
Billroth-II-type reconstruction. Especially, it is important to decline the incidence of
pancreatic fistula, because pancreatic fistula affects a postoperative course. However,
there is no report that demonstrated postoperative complications of isolated Roux-en-Y
compared with those of Billroth-II-type reconstruction. We conducted a prospective
randomized trial on patients who underwent pancreaticoduodenectomy.

Patients with pancreatico-biliary disease who were performed pancreaticoduodenectomy at
Wakayama Medical University Hospital.

The primary endpoint was defined as the incidence of pancreatic fistula. The secondary
endpoints were the incidence of other postoperative complications, mortality, delayed
gastric emptying, intra-abdominal hemorrhage, and intra-abdominal abscess. Patients were
recruited into this study before surgery, on the basis of whether pancreatic head resection
was anticipated at Wakayama Medical University Hospital (WMUH) for pancreatic head and
periampullary disease, and appropriate informed consent was obtained. Exclusion criteria was
1) young patients (less than 20-year-old), 2) patients with severe complications which were
possible to prolong hospital stay, 3) patients undergone hemodialysis, 4) patients combined
resection of other organs, 5) patients who were diagnosed inadequacy for this study by a
physician, and 6) patients without an informed consent.


Inclusion Criteria:



- the patients had undergone pancreatic head resection at Wakayama Medical University
the patients obtained appropriate informed consent

Exclusion Criteria:

- young patients (less than 20-years-old)

- patients with severe complications which were possible to prolong hospital stay

- patients undergone hemodialysis

- patients combined resection of other organs

- patients who were diagnosed inadequacy for this study by a physician

- patients without an informed consent

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

the incidence of pancreatic fistula

Outcome Time Frame:

3 months after operation

Safety Issue:

Yes

Principal Investigator

Masaji Tani, MD

Investigator Role:

Study Chair

Investigator Affiliation:

Wakayama Medical University

Authority:

Japan: Ministry of Health, Labor and Welfare

Study ID:

WP-0901

NCT ID:

NCT00915863

Start Date:

June 2009

Completion Date:

March 2014

Related Keywords:

  • Pancreatic Neoplasms
  • Bile Duct Neoplasms
  • Ampullary Neoplasms
  • Duodenal Neoplasms
  • Pancreatitis
  • pancreaticoduodenectomy
  • pancreatic fistula
  • reconstruction
  • isolated Roux-en-Y
  • Bile Duct Neoplasms
  • Neoplasms
  • Duodenal Neoplasms
  • Pancreatic Neoplasms
  • Pancreatitis

Name

Location